Centre creating 'artificial scarcity' of COVID-19 vaccines to benefit Bharat Biotech, SII, says AAP
AAP spokesperson Atishi said the government's vaccine drive has stopped in schools and this is the case throughout the country while in private hospitals, vaccination is still going on at different rates.
May 28, 2021, 16:52 PM IST
Begin vaccination programme across the country on war footing: Saurabh Bhardwaj urges Centre
Aam Aadmi Party chief spokesperson Saurabh Bhardwaj has said that most of the COVID-19 deaths in India have occurred among people under 45 -- who have not yet received even a single dose of the vaccine.
May 25, 2021, 16:44 PM IST
Key stakeholders come together ahead of WHO-Bharat Biotech meet on Covaxin approval
Bharat Biotech submitted application to the WHO for Emergency Use Listing (EUL) on April 19.
May 24, 2021, 21:24 PM IST
No Covaxin available for second doses to 45+ category after Monday: AAP MLA Atishi
AAP MLA Atishi said, "For 45+, healthcare/frontline workers, Covaxin’s stock left for less than 1 day, and Covishield’s stock remaining for 7 days. 44,676 vaccines administered on Saturday in Delhi. Nearly 11,51,356 people were fully vaccinated with both doses."
May 24, 2021, 16:37 PM IST
Delhi: Third 'booster' dose trial for Covaxin begins at AIIMS
The clinical trials of the third dose of indigenous Covid-19 vaccine, the COVAXIN, as a booster dose, six months after administering the second dose, began in All India Institute of Medical Science, Delhi today.
May 24, 2021, 16:18 PM IST
Bharat Biotech applies for WHO approval, pre-submission meeting soon
Hyderabad based Bharat Biotech has submitted an application to the WHO for Emergency Use Listing(EUL), becoming the 2nd made in India vaccine to apply at the global body for authorization.
May 24, 2021, 15:25 PM IST
COVID Vaccination: Trial of booster dose of Covaxin starts today
Continuous efforts are being made to prevent corona infection. In this connection, the trial of the booster dose of Covaxin has also started from today. The booster dose may be given after the second dose of the corona vaccine.
May 24, 2021, 13:44 PM IST
COVID-19: Covaxin's paediatric trials may begin in June, Bharat Biotech expects WHO approval by end of Q3 or Q4
Dr Raches Ella also said that Bharat Biotech will be ramping up the manufacturing capacity of Covaxin to 700 million doses by the end of this year.
May 24, 2021, 07:25 AM IST
CBSE Class 12 board exams: 'Not right time to conduct exams', says Delhi govt
Deputy Chief Minister Manish Sisodia said this during a high-level meeting called by the Ministry of Education to decide the fate of the pending Class 12 board exams.
May 23, 2021, 17:31 PM IST
Exclusive: Bharat Biotech confident on COVID-19 vaccine production commitments, highlights need to ease out supply chains
Bharat Biotech said that if all goes well, it will complete the clinical trials for the 2-18 age group within the three months timeline.
Bharat Biotech to ramp up Covaxin production to additional 200 million doses per year
Bharat Biotech, the company which manufactures COVID-19 vaccine Covaxin, has decided to ramp up its production to manufacture additional 200 million doses per year.
May 20, 2021, 22:07 PM IST
No intimation from Centre of any new supply of vaccine for 18-44 age group as of yet: Atish
Atishi said that for those above 45 and healthcare/frontline workers, Covaxin’s stock is left for 1 day, and Covishield’s stock is remaining for 3 days.
May 20, 2021, 16:31 PM IST
Covaxin trials for 2-18 age group to begin in 10-12 days: Niti Aayog’s Dr VK Paul
Covaxin received the DCGI nod to conduct clinical trials in children on May 11.
May 18, 2021, 22:12 PM IST
Delhi's Covishield stock running out, may have to stop vaccination soon: Atishi
Releasing the city's latest "vaccination bulletin", Atishi said the city will have only three days of Covishield stock left for the 18-44 age group after Tuesday evening.
May 18, 2021, 21:16 PM IST
Adverse effects of Covishield: 26 cases of miniscule bleeding, clotting reported, says government
The Union Health Ministry said in a statement on Monday that over 23,000 adverse events have been reported since the vaccination drive involving Covishield and Covaxin vaccines started in the country and of these 700 cases were reported to be serious.
May 17, 2021, 20:18 PM IST
Bharat Biotech's Covaxin effective against new COVID-19 variants, reveals study
A recent study has revealed that Bharat Biotech’s Covaxin produces neutralising titres against all new key variants of COVID-19 including the double mutant strain B.1.617 and B.1.1.7.
May 16, 2021, 12:26 PM IST
Covishield stock to last 6 days for 45+ age group in Delhi says AAP MLA Atishi
The Delhi government received over 1.73 lakh doses of Covishield on Saturday (May 15) and the stocks of this vaccine will last for another six days for the 45 plus age group as well as frontline and health care workers
May 15, 2021, 18:53 PM IST
Hyderabad based Bharat Biotech to start producing coronavirus vaccines in Pune
The Hyderabad-based Bharat Biotech International Ltd will soon start manufacturing Covid-19 vaccines in Pune, through subsidiary Biovet Pvt Ltd, Maharashtra Deputy Chief Minister Ajit Pawar announced.
May 14, 2021, 19:45 PM IST
192 lakh COVID vaccines to states/UTs from May 16-31, says Health ministry
The Union health ministry said a total of 191.99 lakh doses of COVID-19 vaccines--Covishield and Covaxin--will be supplied to states/UTs free of cost from May 16 to May 31.
May 14, 2021, 15:51 PM IST
Centre plans to have 8 COVID-19 vaccines to inoculate all its citizens by end of 2021
The Niti Aayog member (Health) Dr VK Paul on Thursday (May 13, 2021) outlined the central government’s plan which involved a total of eight COVID-19 vaccines that will help India inoculate all its citizens by the end of 2021.
May 14, 2021, 11:57 AM IST
